Mixed oral candidiasis in type 2 diabetic patients: Identification and spectrum of sensitivity

IF 0.8 4区 医学 Q4 TROPICAL MEDICINE Biomedica Pub Date : 2023-08-31 DOI:10.7705/biomedica.6878
Javier Araiza, Valentín Sánchez-Pedraza, Ana Karen Carrillo, Denise Fernández-Samar, Jazmín Tejeda, Alexandro Bonifaz
{"title":"Mixed oral candidiasis in type 2 diabetic patients: Identification and spectrum of sensitivity","authors":"Javier Araiza, Valentín Sánchez-Pedraza, Ana Karen Carrillo, Denise Fernández-Samar, Jazmín Tejeda, Alexandro Bonifaz","doi":"10.7705/biomedica.6878","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Patients with type 2 diabetes mellitus are susceptible to acquire Candida spp. infections, sometimes involving more than one species. The resistance of some species to antimycotic agents can cause treatment failure.</p><p><strong>Objectives: </strong>To determine the frequency and clinical varieties of mixed oral candidiasis in patients with type 2 diabetes mellitus, the involved species, and its sensitivity spectra when exposed to antifungals used as candidiasis treatment.</p><p><strong>Material and methods: </strong>We developed an analytical cross-sectional study with 72 patients with type 2 diabetes mellitus with hyperglycemia (HbA1C ≥ 7%) and an oral candidiasis diagnosis. The causal species of oral candidiasis were identified through microbiological techniques, and sensitivity tests were carried out using the diffusion method in a plate with strips (E-test ®).</p><p><strong>Results: </strong>We included 72 patients in the study, 32 (44%) males and 40 (56%) females. Patients were divided into three age groups: young adults (17%), adults (74%), and older adults (9%). The mean age of the patients was 51 years. No significant differences were found between mixed oral candidiasis and groups (sex and age), or between mixed oral candidiasis and gender, glycosylated hemoglobin level (HbA1C), antihyperglycemic treatment, or type 2 diabetes mellitus time of diagnosis. We found a correlation between the adult group and development of mixed or simple oral candidiasis. The results showed eight (13%) cases of mixed oral candidiasis: seven with a coinfection of two species and one with a coinfection of three species. The identified species were Candida albicans, C. glabrata, C. dubliniensis, C. kefyr, C. tropicalis, and C. krusei. Most of these species presented sensitivity against ketoconazole and fluconazole, and higher resistance to itraconazole.</p><p><strong>Conclusions: </strong>Mixed oral candidiasis occurs in approximately 10% of the patients with type 2 diabetes mellitus and its treatment can be ineffective when the etiological agent is not identified.</p>","PeriodicalId":9186,"journal":{"name":"Biomedica","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586404/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7705/biomedica.6878","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TROPICAL MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Patients with type 2 diabetes mellitus are susceptible to acquire Candida spp. infections, sometimes involving more than one species. The resistance of some species to antimycotic agents can cause treatment failure.

Objectives: To determine the frequency and clinical varieties of mixed oral candidiasis in patients with type 2 diabetes mellitus, the involved species, and its sensitivity spectra when exposed to antifungals used as candidiasis treatment.

Material and methods: We developed an analytical cross-sectional study with 72 patients with type 2 diabetes mellitus with hyperglycemia (HbA1C ≥ 7%) and an oral candidiasis diagnosis. The causal species of oral candidiasis were identified through microbiological techniques, and sensitivity tests were carried out using the diffusion method in a plate with strips (E-test ®).

Results: We included 72 patients in the study, 32 (44%) males and 40 (56%) females. Patients were divided into three age groups: young adults (17%), adults (74%), and older adults (9%). The mean age of the patients was 51 years. No significant differences were found between mixed oral candidiasis and groups (sex and age), or between mixed oral candidiasis and gender, glycosylated hemoglobin level (HbA1C), antihyperglycemic treatment, or type 2 diabetes mellitus time of diagnosis. We found a correlation between the adult group and development of mixed or simple oral candidiasis. The results showed eight (13%) cases of mixed oral candidiasis: seven with a coinfection of two species and one with a coinfection of three species. The identified species were Candida albicans, C. glabrata, C. dubliniensis, C. kefyr, C. tropicalis, and C. krusei. Most of these species presented sensitivity against ketoconazole and fluconazole, and higher resistance to itraconazole.

Conclusions: Mixed oral candidiasis occurs in approximately 10% of the patients with type 2 diabetes mellitus and its treatment can be ineffective when the etiological agent is not identified.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2型糖尿病患者混合性口腔念珠菌感染的鉴别及敏感性谱
引言:2型糖尿病患者易感染念珠菌。感染有时涉及多个物种。某些物种对抗真菌剂的耐药性可能导致治疗失败。目的:确定2型糖尿病患者混合性口腔念珠菌感染的频率和临床类型,涉及的种类,以及接触用作念珠菌感染治疗的抗真菌药物时的敏感性谱。材料和方法:我们对72例2型糖尿病合并高血糖(HbA1C≥7%)并经口腔念珠菌感染诊断的患者进行了横断面分析研究。通过微生物学技术确定了口腔念珠菌感染的病因,并使用带条平板(E-test®)的扩散法进行了敏感性测试。结果:我们纳入了72名研究患者,其中32名(44%)为男性,40名(56%)为女性。患者分为三个年龄组:年轻人(17%)、成年人(74%)和老年人(9%)。患者的平均年龄为51岁。混合性口腔念珠菌感染与各组(性别和年龄)之间,或混合性口腔念珠菌病与性别、糖化血红蛋白水平(HbA1C)、抗高血糖治疗或2型糖尿病诊断时间之间没有显著差异。我们发现成人组与混合性或单纯性口腔念珠菌感染的发展之间存在相关性。结果显示,8例(13%)混合性口腔念珠菌感染病例:7例同时感染两种,1例同时感染三种。已鉴定的物种为白色念珠菌、光滑念珠菌、杜氏念珠菌、凯菲尔念珠菌、热带念珠菌和克鲁塞念珠菌。这些菌种大多对酮康唑和氟康唑敏感,对伊曲康唑耐药性较高。结论:大约10%的2型糖尿病患者会发生混合性口腔念珠菌感染,如果病因不明确,其治疗可能无效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biomedica
Biomedica 医学-热带医学
CiteScore
1.60
自引率
0.00%
发文量
76
审稿时长
>12 weeks
期刊介绍: Biomédica is the quarterly journal of the Instituto Nacional de Salud of Colombia [Colombia’s National Health Institute]. Its purpose is to publish the results of original research that contributes meaningfully to knowledge in health and biomedical sciences.
期刊最新文献
Fusariosis in cancer patients: 13 case series report and literature review Tinea capitis outbreak and other superficial mycosis in an urban community of Medellín Make the diagnosis - Second part Make the diagnosis - First part Fast and cost-effective protocol to produce Paracoccidioides spp. antigens
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1